1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banerjee, S; Basu, M; Basu, S; Bradley, M; Inokuchi, J; Ma, R; Mikulla, B; Moulton, C | 1 |
| Billups, C; Cabot, MC; Maurer, BJ; Melton, L; Reynolds, CP | 1 |
2 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Neoplasms
| Article | Year |
|---|---|
Apoptosis of human carcinoma cells in the presence of inhibitors of glycosphingolipid biosynthesis: I. Treatment of Colo-205 and SKBR3 cells with isomers of PDMP and PPMP.
Topics: Antineoplastic Agents; Apoptosis; Carbon Radioisotopes; Caspase 3; Caspases; Cell Line, Tumor; Ceramides; DNA Fragmentation; Enzyme Activation; Enzyme Inhibitors; Glycosphingolipids; Humans; Meperidine; Molecular Structure; Morpholines; Neoplasms; Serine; Stereoisomerism | 2004 |
Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism.
Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Apoptosis; Ceramides; Drug Synergism; Enzyme Inhibitors; Estrogen Receptor Modulators; Fenretinide; Glucosyltransferases; Humans; Morpholines; Necrosis; Neoplasms; Protein Kinase C; Sphingosine; Tamoxifen; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2000 |